| abstract |
The present invention relates, in some aspects, to methods and compositions for the production of immunogenic compositions. In some embodiments, the invention relates to host cells that have been ex vivo treated with one or more oligonucleotide agents to control and / or reduce differentiation of the host cell. In some embodiments, the compositions and methods disclosed herein are useful as immunogenic modulators for the treatment of cancer. |